Clinical

Dataset Information

Loperamide vs. Placebo’s Effect on Ileostomy Output: A Clinical Randomized Blinded Cross-over Study


ABSTRACT: Clinical experience show limited effect of the drug Loperamide used to decrease output in stoma patients. Therefore the investigators see the need for a randomized blinded clinical trial to determine the effect of Loperamide opposite Placebo. Loperamide will be evaluated in relation to the following parameters * Change in ileostomy output in g/day in relation to oral intake * Quantification of the change in intestinal transit time using a radiopaque marker * The patient´s own assessment on which period they received Loperamide or Placebo

DISEASE(S): Short Bowel Syndrome,Ulcerative Colitis,Patients With Ileostomy Because Of Ulcerative Colitis, Rectal Cancer Or Short Bowel Syndrom,Diarrhea,Rectal Cancer,Patienter Med Ileostomi Opereret For Colitis Ulcerosa, Rectumcancer Eller Korttarmssyndrom

PROVIDER: 2176432 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR